Skip to main content
ES
v1.2
Log in
G

Glenmark Pharma

GLENMARK PHARMANSE
₹2,265+0.00 (+0.00%)
Market Cap
₹62,829Cr.
P/E Ratio
20.1
P/B Ratio
6.09
EPS (TTM)
₹112.69
Div Yield
0.22%
ROCE
39.8%
ROE
23.6%
52W Low: ₹1,79352W High: ₹2,538

At a glance

  • Sales have grown 14.0% a year over three years.
  • Debt is 0.06× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Glenmark_Pharma — Price
Interval
||
Style
Failed: 503

Scorecard

Market: risk-off · breadth 37
4/8Minerviniuptrend checks met
64RS Rankvs all stocks, 1–99
bullRSI Regimemomentum range
34 ▲Trend (ADX)trend strength
0/4CAN SLIMprice & volume checks
downSupertrendprice vs trailing line
downVolume Flowbuying vs selling volume

Factual technical classifications from price/volume data — research signals, not investment advice. Hover or tap any badge for what it means.

Evenstocks Score

Middle third
6.8/ 10Overall
7/ 10Valuation
9/ 10Quality
4/ 10Fundamental
7/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 20.1P/E: 20.1 | P/B: 6.09
Growth
GrowingSales CAGR — 3Y: 14% · 1Y: 33%
Profitability
High MarginROCE: 39.8% | ROE: 23.6%

Key Metrics

Valuation
PEG Ratio 0.33
Price / Sales 3.54x
Price / FCF 30.1x
Book Value ₹372
Margins & returns
Operating Margin 27%
Net Margin 10.1%
Return on Assets 9.0%

Frequently Asked Questions

MarketsPortfolioChart